Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00033
|
|||||
Drug Name |
Atenolol
|
|||||
Synonyms |
(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide; (+-)-Atenolol; (+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; (1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; (inverted question mark)-Atenolol; 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol; 2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid; 2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide; 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; 2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide; 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide; 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide; 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide; 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide; 4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide; 4-[2-Hydroxy-3-(isopropylamino)-propoxy]phenylacetamide; A 7655; Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl); Aircrit; Alinor; Altol; Anselol; Antipressan; Apo-Atenolol; Atcardil; Atecard; Atehexal; Atenblock; Atendol; Atenet; Ateni; Atenil; Atenol; Atenol 1A pharma; Atenol AL; Atenol Atid; Atenol Cophar; Atenol Fecofar; Atenol GNR; Atenol Gador; Atenol Genericon; Atenol Heumann; Atenol MSD; Atenol NM Pharma; Atenol Nordic; Atenol PB; Atenol Quesada; Atenol Stada; Atenol Tika; Atenol Trom; Atenol acis; Atenol ct; Atenol von ct; Atenol-Mepha; Atenol-Wolff; Atenol-ratiopharm; Atenolin; Atenolol (JP15/USP/INN); Atenolol [USAN:INN:BAN:JAN]; Atenololum; Atenololum [INN-Latin]; Atenomel; Atereal; Aterol; Betablok; Betacard; Betasyn; Betatop Ge; Blocotenol; Blokium; Cardaxen; Cardiopress; Corotenol; Cuxanorm; Duraatenolol; Duratenol; Evitocor; Farnormin; Felo-Bits; Hipres; Hypoten; Ibinolo; Internolol; Jenatenol; Juvental; Lo-ten; Loten; Lotenal; Myocord; Neatenol; Normalol; Normiten; Noten; Oraday; Ormidol; Panapres; Plenacor; Premorine; Prenolol; Prenormine; Prinorm; Scheinpharm Atenol; Seles beta; Selobloc; Serten; Servitenol; Stermin; Tenidon; Teno-basan; Tenobloc; Tenoblock; Tenolol; Tenoprin; Tenormin; Tenormin (TN); Tenormine; Tenormine [French]; Tensimin; Tensotin; Tredol; Unibloc; Uniloc; Vascoten; Vericordin; Wesipin; Xaten
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
Therapeutic Class |
Antihypertensive Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C14H22N2O3
|
|||||
Canonical SMILES |
CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
|
|||||
InChI |
InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
|
|||||
InChIKey |
METKIMKYRPQLGS-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 29122-68-7
|
|||||
Pharmaceutical Properties | Molecular Weight | 266.34 | Topological Polar Surface Area | 84.6 | ||
Heavy Atom Count | 19 | Rotatable Bond Count | 8 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
0.2
|
|||||
PubChem CID | ||||||
PubChem SID |
11335232
, 11360471
, 11364258
, 11366820
, 11369382
, 11372514
, 11373929
, 11377544
, 11461443
, 11485218
, 11489227
, 11491263
, 11492250
, 11495178
, 11528603
, 12014149
, 14799140
, 17404684
, 17436233
, 24277748
, 25623439
, 26612180
, 26679879
, 26747108
, 26747109
, 26751696
, 29221423
, 3206539
, 46506915
, 47193738
, 47216616
, 47216617
, 47885249
, 48184827
, 48334310
, 48415588
, 49703475
, 49878510
, 50085956
, 50104387
, 50104388
, 50330349
, 5313665
, 53777227
, 53789685
, 7847302
, 7978734
, 8149723
, 8151519
, 855957
|
|||||
ChEBI ID |
CHEBI:2904
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | OATP1A2 | Transporter Info | Organic anion transporting polypeptide 1A2 | Substrate | [2] | |
OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [3] | ||
P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [4] | ||
References | ||||||
1 | Atenolol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol. 2010 Nov;70(5):645-55. | |||||
3 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
4 | Interaction of digoxin with antihypertensive drugs via MDR1. Life Sci. 2002 Feb 15;70(13):1491-500. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.